Study of early stages of amyloid Aβ13-23 formation using molecular dynamics simulation in implicit environments
暂无分享,去创建一个
[1] M. Berkowitz,et al. Structure of the amyloid-beta (1-42) monomer absorbed to model phospholipid bilayers: a molecular dynamics study. , 2009, The journal of physical chemistry. B.
[2] Thomas L. Williams,et al. Membrane and surface interactions of Alzheimer’s Aβ peptide – insights into the mechanism of cytotoxicity , 2011, The FEBS journal.
[3] Yinan Lin,et al. Structure, orientation, and surface interaction of Alzheimer amyloid-β peptides on the graphite. , 2012, Langmuir : the ACS journal of surfaces and colloids.
[4] R. Nussinov,et al. Modeling the Alzheimer Abeta17-42 fibril architecture: tight intermolecular sheet-sheet association and intramolecular hydrated cavities. , 2007, Biophysical journal.
[5] Anselm H. C. Horn,et al. Rational design of β-sheet ligands against Aβ42-induced toxicity. , 2011, Journal of the American Chemical Society.
[6] A Caflisch,et al. A molecular dynamics approach to the structural characterization of amyloid aggregation. , 2006, Journal of molecular biology.
[7] H. Shao,et al. Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease. , 1999, Journal of molecular biology.
[8] F. Stellato,et al. Zn induced structural aggregation patterns of β-amyloid peptides by first-principle simulations and XAS measurements. , 2012, Metallomics : integrated biometal science.
[9] Sarah Rauscher,et al. Molecular mechanism of β‐sheet self‐organization at water‐hydrophobic interfaces , 2011, Proteins.
[10] M. Sathya,et al. BACE1 in Alzheimer's disease. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[11] V. Andrisano,et al. Amyloid β-peptide 25-35 self-assembly and its inhibition: a model undecapeptide system to gain atomistic and secondary structure details of the Alzheimer's disease process and treatment. , 2012, ACS chemical neuroscience.
[12] R. Tycko. Solid-state NMR studies of amyloid fibril structure. , 2011, Annual review of physical chemistry.
[13] R. Riek,et al. 3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .
[14] Charles D. Schwieters,et al. Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue , 2013, Cell.
[15] F. Stellato,et al. Metal binding in amyloid β-peptides shows intra- and inter-peptide coordination modes , 2006, European Biophysics Journal.
[16] B. Urbanc,et al. Insights into Aβ aggregation: a molecular dynamics perspective. , 2013, Current topics in medicinal chemistry.
[17] P. Wong,et al. Amyloid precursor protein processing and Alzheimer's disease. , 2011, Annual review of neuroscience.
[18] Themis Lazaridis,et al. Implicit solvent simulations of peptide interactions with anionic lipid membranes , 2004, Proteins.
[19] Jie Zheng,et al. Molecular dynamics simulations of low-ordered alzheimer β-amyloid oligomers from dimer to hexamer on self-assembled monolayers. , 2011, Langmuir : the ACS journal of surfaces and colloids.
[20] A. Bonvin,et al. The α‐to‐β Conformational Transition of Alzheimer's Aβ‐(1–42) Peptide in Aqueous Media is Reversible: A Step by Step Conformational Analysis Suggests the Location of β Conformation Seeding , 2006 .
[21] S. Saxena,et al. Zn(II) ions substantially perturb Cu(II) ion coordination in amyloid-β at physiological pH. , 2013, The journal of physical chemistry. B.
[22] Ehud Gazit,et al. A possible role for π‐stacking in the self‐assembly of amyloid fibrils , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] Michele Vendruscolo,et al. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism , 2013, Proceedings of the National Academy of Sciences.
[24] Kenjiro Ono,et al. Structure–neurotoxicity relationships of amyloid β-protein oligomers , 2009, Proceedings of the National Academy of Sciences.
[25] J. Scheiber,et al. Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine, and butyrylcholine esterases. , 2010, Bioorganic & medicinal chemistry.
[26] E. Gazit. Mechanisms of amyloid fibril self‐assembly and inhibition , 2005, The FEBS journal.
[27] Justin A. Lemkul,et al. Aggregation of Alzheimer's amyloid β-peptide in biological membranes: a molecular dynamics study. , 2013, Biochemistry.
[28] T. Lazaridis. Effective energy function for proteins in lipid membranes , 2003, Proteins.
[29] G. Evin,et al. β‐Site APP‐cleaving enzyme 1 trafficking and Alzheimer’s disease pathogenesis , 2012, Journal of neurochemistry.
[30] G. Logroscino,et al. Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulation. , 2011, Current medicinal chemistry.
[31] C. Schwieters,et al. Molecular Structure of beta-Amyloid Fibrils in Alzheimer's Disease Brain Tissue. , 2013 .
[32] Brigita Urbanc,et al. Computer Simulations of Alzheimers Amyloid β-Protein Folding and Assembly , 2006 .
[33] Chewook Lee,et al. Charactering Amyloid-Beta Protein Misfolding from Molecular Dynamics Simulation with Explicit Water , 2010 .
[34] V. Lee,et al. Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles* , 2011, The Journal of Biological Chemistry.
[35] T. Härd,et al. Amyloid-β Protofibrils: Size, Morphology and Synaptotoxicity of an Engineered Mimic , 2013, PloS one.
[36] U. Holzgrabe,et al. Design, Synthesis and Evaluation of Novel 2‐(Aminoalkyl)‐isoindoline‐1,3‐dione Derivatives as Dual‐Binding Site Acetylcholinesterase Inhibitors , 2012, Archiv der Pharmazie.
[37] M. Berkowitz,et al. Interaction between amyloid-beta (1-42) peptide and phospholipid bilayers: a molecular dynamics study. , 2009, Biophysical journal.
[38] Jingdai Wang,et al. Comparative molecular dynamics study of Abeta adsorption on the self-assembled monolayers. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[39] D. Holtzman,et al. Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement. , 2012, Current opinion in neurology.
[40] Ruth Nussinov,et al. Zinc ions promote Alzheimer Aβ aggregation via population shift of polymorphic states , 2010, Proceedings of the National Academy of Sciences.
[41] A. D'Ursi,et al. Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain. , 2002, European journal of biochemistry.
[42] Lei Gu,et al. Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils , 2013, Journal of neurochemistry.
[43] S. DeKosky,et al. Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress. , 2013, Annual review of medicine.
[44] M. Kirkitadze,et al. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. , 2001, Journal of molecular biology.
[45] B. Allinquant,et al. Functions of Aβ, sAPPα and sAPPβ : similarities and differences , 2012, Journal of neurochemistry.
[46] U. Holzgrabe,et al. 1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-β aggregation crossing the blood-brain barrier. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[47] C. Robinson,et al. Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. , 2009, Nature chemistry.
[48] R. Chiaraluce,et al. Computational and Experimental Studies on β-Sheet Breakers Targeting Aβ1–40 Fibrils , 2014, The Journal of Biological Chemistry.
[49] U. Holzgrabe,et al. Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.